Two capsule studies reported a mean 91% attack-rate reduction at 96 weeks; FDA based approval on manufacturing, safety and tolerability data versus capsules.

I wound up in the emergency room with a heart arrhythmia. It kept beating too fast, too slow and skipping beats, one after ...

Talks cover a blood pressure presentation and a Phase 3 trial design for an investigational atrial-fibrillation use; meetings ...

I wound up in the emergency room with a heart arrhythmia. It kept beating too fast, too slow and skipping beats, one after ...

Most people walk through life with a heart condition they know nothing about. Atrial fibrillation, commonly called AFib, is ...